Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 45 articles for Fingolimod

Then save them, add them to a collection or cite them together.
  1. Research article · 20 Jan 2020

    Is Gender Associated to Extended Cardiac Monitoring after First Dose of Fingolimod and Level of Satisfaction with the Monitoring Experience in Relapsing-Remitting Multiple Sclerosis Patients? A Post-hoc Analysis of the BEAT Study

    Journal of Multiple Sclerosis · Volume 7, Issue 2

    Objective: Fingolimod, a second-line therapy for relapsing-remitting multiple sclerosis, may cause transitory effects on heart rate and atrioventricular conduction that may result in bradycardia and atrioventricular…

  2. Conference abstract · 2017

    Effectiveness of fingolimod in patients with relapsing-remitting multiple sclerosis in daily clinical practice in Spain: Results from a multivariate pool analysis called Fingoview

    Journal of Neurology & Neurophysiology

    Introduction: Once-daily Fingolimod (GilenyaÃ?®, Novartis Pharma AG) is a sphingosine 1-phosphate receptor modulator approved for relapsing MS treatment. Continuous collection and analysis of real world effectiveness…

  3. Conference abstract · 11 Jul 2016

    Fingolimod lifts the burden of lymphoma

    Cancer Science & Therapy

    prognosis highly depends on desperation of neoplastic cells at the time of diagnosis. Peroral fingolimod is an immunomodulating drug, approved for treating multiple sclerosis. Peroral fingolimod, after hepatic…

  4. Review article · 18 Mar 2021

    Fingolimod-An Overview

    Journal of Multiple Sclerosis · Volume 8, Issue 3

    Fingolimod (FTY720) is a sphingosine-1-phosphate-receptor modulator that Is administered orally, which is currently being evaluated for the multiple sclerosis treatment

  5. Research article · 31 Jul 2016

    Stability indicating chromatographic method transfer of immunomodulating drug fingolimod from high performance liquid chromatography to new generation ultra performance liquid chromatography with comparative validation study

    Journal of Chemical and Pharmaceutical Research · Volume 8, Issue 7

    solvent consuming and time saving stability indicating reverse phase isocratic chromatographic separation method of Fingolimod has been performed on High performance liquid chromatography (HPLC) system as well

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels